Verdence Capital Advisors LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1719305
HUNT VALLEY, MD
Position in VRTX
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$944,283
New position
Shares Held
1,901
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#341
of 821 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 22%
Shared 0%
None 78%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Verdence Capital Advisors LLC holds $3,978,199 across 8 Biotechnology names. VRTX ranks #3 (23.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
14,342 | $1,013,262 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
12,488 | $977,435 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
1,901 | $944,283 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
954 | $594,857 | |
| 5 | VCEL |
Vericel Corp
|
6,754 | $300,485 | |
| 6 | ATAI |
AtaiBeckley Inc.
|
19,251 | $101,452 | |
| 7 | OCGN |
Ocugen, Inc.
|
26,500 | $40,545 | |
| 8 | GTBP |
GT Biopharma, Inc.
|
12,000 | $5,880 |
All Filings in VRTX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $944,283 | 1,901 | Shares | Sole | 2026-07-29 | |
| No filing history on record for this holder in this stock. | ||||||